Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by TMAN2019on Nov 18, 2019 2:47pm
189 Views
Post# 30366020

RVX today

RVX todayFirst want to thank Bear and others on the other board for their continuation of explanation and inputs  of the science for people like me.

For all you long RVX holders, including me... seen all up and downs, the company now is more valuable than ever before.  Could have been worse, but this is really amazing science and proven is Phase 3!

This was the first trial of its kind and design, primary point was not meet, So what we didn't hit it, we have more information about the science than ever, and more potential associations with BP's. 

RVX is filling new patents as they emerge. Over the years, Don has calmed down and doesn't over excite for no reason as he did back in 2006. Don or whoever it is, the data does not lie and now pharma can take RVX more seriously, 

As for Financing, ORI Star Fund, Dart, HP, etc. is behind RVX. They haven't sold anything. Now with these impressive results before Dec annoncement, either good or bad, there is something very valuable  with this small Company from Calgary.

The way i see it, the risk with this company is less than a month ago, and in my opinion is worth much more. SP does not reflect the value of the company now. 

Exciting times ahead! Hope the SP stays low so I buy more next year through TFSA!

 
Bullboard Posts